EDNRB
Basic information
Region (hg38): 13:77895481-77975529
Previous symbols: [ "HSCR2", "HSCR" ]
Links
Phenotypes
GenCC
Source:
- Waardenburg syndrome type 4A (Strong), mode of inheritance: AD
- Waardenburg syndrome type 4A (Strong), mode of inheritance: AR
- ABCD syndrome (Definitive), mode of inheritance: AD
- Waardenburg syndrome type 2 (Supportive), mode of inheritance: AD
- Waardenburg-Shah syndrome (Supportive), mode of inheritance: AD
- Waardenburg syndrome type 4A (Moderate), mode of inheritance: Semidominant
- Hirschsprung disease, susceptibility to, 2 (Limited), mode of inheritance: Unknown
- Waardenburg syndrome type 4A (Strong), mode of inheritance: AR
- Waardenburg syndrome type 4A (Limited), mode of inheritance: AD
- Waardenburg syndrome type 4A (Moderate), mode of inheritance: AR
- Waardenburg syndrome type 4A (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Waardenburg syndrome type 4A; ABCD syndrome; Hirschsprung disease, susceptibility to, 2 | AD/AR | Audiologic/Otolaryngologic; Gastrointestinal | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Recognition of potential GI manifestations (eg, Hirschsprung disease) may allow prompt treatment | Audiologic/Otolaryngologic; Dermatologic; Gastrointestinal; Ophthalmologic | 7264803; 8001158; 8634719; 7778600; 10528251; 11484199; 11891690; 19764031 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (10 variants)
- Waardenburg syndrome type 4A (4 variants)
- Rare genetic deafness (1 variants)
- ABCD syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EDNRB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 31 | 36 | ||||
missense | 103 | 110 | ||||
nonsense | 11 | |||||
start loss | 0 | |||||
frameshift | 13 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 10 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 48 | 24 | 12 | 84 | ||
Total | 14 | 18 | 160 | 59 | 14 |
Highest pathogenic variant AF is 0.00000659
Variants in EDNRB
This is a list of pathogenic ClinVar variants found in the EDNRB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-77895535-A-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77895620-G-A | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77895737-A-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77895748-C-T | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77895774-T-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77895845-A-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77895891-A-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77895908-T-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 15, 2018) | ||
13-77895942-C-A | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77895981-T-C | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77896033-G-C | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77896035-G-A | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77896136-A-C | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77896145-T-C | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77896153-G-A | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77896159-A-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77896294-C-T | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77896340-A-C | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77896356-T-C | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77896416-T-C | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77896433-G-A | not specified • Hirschsprung disease, susceptibility to, 2 | Benign/Likely benign (Mar 04, 2019) | ||
13-77896538-A-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 12, 2018) | ||
13-77896568-G-T | not specified | Uncertain significance (May 21, 2015) | ||
13-77896600-A-G | Hirschsprung disease, susceptibility to, 2 | Uncertain significance (Jan 13, 2018) | ||
13-77896654-T-C | Hirschsprung disease, susceptibility to, 2 | Benign/Likely benign (Jul 05, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EDNRB | protein_coding | protein_coding | ENST00000377211 | 8 | 24288 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00924 | 0.990 | 125588 | 0 | 8 | 125596 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.18 | 236 | 293 | 0.805 | 0.0000145 | 3437 |
Missense in Polyphen | 31 | 68.129 | 0.45502 | 857 | ||
Synonymous | 0.729 | 106 | 116 | 0.914 | 0.00000607 | 1072 |
Loss of Function | 3.07 | 8 | 24.3 | 0.329 | 0.00000119 | 286 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000907 | 0.0000906 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000443 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Non-specific receptor for endothelin 1, 2, and 3. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. {ECO:0000269|PubMed:7536888}.;
- Disease
- DISEASE: Waardenburg syndrome 4A (WS4A) [MIM:277580]: A disorder characterized by the association of Waardenburg features (depigmentation and deafness) with the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease). {ECO:0000269|PubMed:12189494, ECO:0000269|PubMed:8634719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hirschsprung disease 2 (HSCR2) [MIM:600155]: A disorder of neural crest development characterized by absence of enteric ganglia along a variable length of the intestine. It is the most common cause of congenital intestinal obstruction. Early symptoms range from complete acute neonatal obstruction, characterized by vomiting, abdominal distention and failure to pass stool, to chronic constipation in the older child. {ECO:0000269|PubMed:11471546, ECO:0000269|PubMed:28236341, ECO:0000269|PubMed:8001158, ECO:0000269|PubMed:8630503, ECO:0000269|PubMed:8852660}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: ABCD syndrome (ABCDS) [MIM:600501]: An autosomal recessive syndrome characterized by albinism, black lock at temporal occipital region, bilateral deafness, aganglionosis of the large intestine and total absence of neurocytes and nerve fibers in the small intestine. {ECO:0000269|PubMed:11891690}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous mutations in EDNRB may be responsible for Waardenburg syndrome 2, an autosomal dominant disorder characterized by sensorineural deafness and pigmentary disturbances. {ECO:0000269|PubMed:28236341}.;
- Pathway
- Relaxin signaling pathway - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Endothelin Pathways;Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Prostaglandin Synthesis and Regulation;Signaling by GPCR;Signal Transduction;role of egf receptor transactivation by gpcrs in cardiac hypertrophy;ion channels and their functional role in vascular endothelium;activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor;chrebp regulation by carbohydrates and camp;role of -arrestins in the activation and targeting of map kinases;activation of camp-dependent protein kinase pka;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);roles of arrestin dependent recruitment of src kinases in gpcr signaling;GPCR ligand binding;-arrestins in gpcr desensitization;G alpha (q) signalling events;GPCR downstream signalling;Endothelins
(Consensus)
Recessive Scores
- pRec
- 0.729
Intolerance Scores
- loftool
- 0.360
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.801
- hipred
- Y
- hipred_score
- 0.761
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.584
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ednrb
- Phenotype
- immune system phenotype; skeleton phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; neoplasm; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- ednrba
- Affected structure
- iridophore
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;neural crest cell migration;positive regulation of protein phosphorylation;regulation of pH;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase activity;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;nervous system development;peripheral nervous system development;posterior midgut development;aging;regulation of blood pressure;positive regulation of cell population proliferation;negative regulation of neuron maturation;response to organic cyclic compound;vein smooth muscle contraction;sensory perception of pain;calcium-mediated signaling;cGMP-mediated signaling;melanocyte differentiation;regulation of fever generation;negative regulation of cellular protein metabolic process;enteric smooth muscle cell differentiation;positive regulation of urine volume;positive regulation of renal sodium excretion;epithelial fluid transport;vasoconstriction;vasodilation;negative regulation of apoptotic process;macrophage chemotaxis;response to pain;enteric nervous system development;regulation of epithelial cell proliferation;regulation of sensory perception of pain;positive regulation of penile erection;cellular response to lipopolysaccharide;endothelin receptor signaling pathway;response to endothelin
- Cellular component
- plasma membrane;integral component of plasma membrane;nuclear membrane;membrane raft
- Molecular function
- endothelin receptor activity;protein binding;peptide hormone binding;type 1 angiotensin receptor binding